2012
DOI: 10.1016/j.ajo.2011.12.017
|View full text |Cite
|
Sign up to set email alerts
|

Second-generation Trabecular Meshwork Bypass Stent (iStent inject) Increases Outflow Facility in Cultured Human Anterior Segments

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
77
0
2

Year Published

2012
2012
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 103 publications
(88 citation statements)
references
References 21 publications
1
77
0
2
Order By: Relevance
“…At the time of this report, laboratory evidence for improvement in outflow resistance has been reported only for intracanalicular procedures. 17,18 Such evidence is critical in validating the claimed mechanism of action for procedures that improve outflow. In a research setting, a single variable (microstent versus sham) can be controlled while eliminating or keeping other variables constant.…”
Section: Discussionmentioning
confidence: 99%
“…At the time of this report, laboratory evidence for improvement in outflow resistance has been reported only for intracanalicular procedures. 17,18 Such evidence is critical in validating the claimed mechanism of action for procedures that improve outflow. In a research setting, a single variable (microstent versus sham) can be controlled while eliminating or keeping other variables constant.…”
Section: Discussionmentioning
confidence: 99%
“…32 Devices currently being inserted into SC in the operating room to bypass the TM are thought to achieve their best effect when placed near CCO; at the same time, efforts are made to avoid damage to or occlusion of CCO. The positioning of MIGS devices has been evaluated through imaging with SEM, 45,46 but not OCT. Device placement requirements illustrate the need for in vivo imaging tools to inform device development and to optimize device placement, thereby enabling improvement of clinical outcomes.…”
Section: Discussionmentioning
confidence: 99%
“…Последний лишен Г-образного изгиба и несколько короче, представляя со-бой прямую трубочку-муфту, и предназначен для непо-средственной имплантации через трабекулярную сеть в шлеммов канал. В США он имеет статус неутвержденного устройства, но получил маркировку ЕС [25,29,30].…”
Section: вестник офтальмологии 3 2016unclassified